[1. Benjaminov FS. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut. 2003;52(9):1355-1362. doi:10.1136/gut.52.9.135510.1136/gut.52.9.1355177379712912870]Open DOISearch in Google Scholar
[2. Kawut SM, Krowka MJ, Trotter JF, et al. Clinical risk factors for portopulmonary hypertension. Hepatology. 2008;48(1):196-203. doi:10.1002/hep.2227510.1002/hep.2227518537192282488518537192]Open DOISearch in Google Scholar
[3. Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67-119. doi:10.1093/eurheartj/ehv31710.1093/eurheartj/ehv31726320113]Open DOISearch in Google Scholar
[4. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32(5):1371-1385. doi:10.1183/09031936.0001560810.1183/09031936.0001560818978137]Open DOISearch in Google Scholar
[5. Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J. 2007;30(4):715-721. doi:10.1183/09031936.0010720610.1183/09031936.001072061762611117626111]Open DOISearch in Google Scholar
[6. Mateo Porres-Aguilar, Jose T Altamirano, Aldo Torre-Delgadillo, Michael R Charlton, Andreas Duarte Rojo, Portopulmonary hypertension and hepatopulmonary syndrome: a clinical-oriented overview, Eur Resp Rev, 2012, 21 (125): 223-233)10.1183/09059180.0000721122941887]Search in Google Scholar
[7. Sonja D. Bartolome, Michael J. Krowka Pulmonary Complications of Intra-abdominal Disease part 13, p 2496-1508 in Fishman’s Pulmonary Diseases and Disorders Fifth Edition McGrawHill, 2015, ISBN: 978-1-25-958912-6]Search in Google Scholar
